Dependence on Sales of the Mighty Series
First written in FY2017. 2 of 5 entries say "Worsened", first in FY2018. Latest entry: FY2026.
Ubicom Holdings moved to the "Worse" side of this theme in 2018, 5 years before the typical company in this theme (2023).
The whole theme swung hardest in 2018: 9 of 44 companies on the "Worse" side.
33 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「In the medical business operated by our Group, the Mighty series of claims-review software has become a core product, accounting for approximately 28% of consolidated net sales for the fiscal year ended March 2026.」
Dependence on the Mighty series remained at approximately 28% of consolidated net sales for the fiscal year ended March 2026, with no significant change from the approximately 28% previously disclosed. - FY2020MitigatedAnnual report
「In the medical business operated by our Group, the Mighty series of claims-review software has become a core product, accounting for approximately 28% of consolidated net sales for the fiscal year ended March 2020.」
Dependence on the Mighty series declined from approximately 30% of consolidated net sales for the fiscal year ended March 2019 to approximately 28% for the fiscal year ended March 2020. - FY2019WorsenedAnnual report
「In the medical business operated by our Group, the Mighty series of claims-review software has become a core product, accounting for approximately 30% of consolidated net sales for the fiscal year ended March 2019.」
Dependence on the Mighty series increased from approximately 29% of consolidated net sales for the fiscal year ended March 2018 to approximately 30% for the fiscal year ended March 2019. - FY2018WorsenedAnnual report
「In the medical business operated by our Group, the Mighty series of claims-review software has become a core product, accounting for approximately 29% of consolidated net sales for the fiscal year ended March 2018.」
Dependence on the Mighty series increased from approximately 28% of consolidated net sales for the fiscal year ended March 2017, as previously disclosed, to approximately 29% for the fiscal year ended March 2018. - FY2017First statedAnnual report
「The Mighty series of claims-review software has become a core product, accounting for approximately 28% of consolidated net sales for the fiscal year ended March 2017.」
The Mighty series accounted for approximately 28% of consolidated net sales for the fiscal year ended March 2017, and the risk of lower sales due to discontinuation of sales or customers switching to products from other companies is disclosed.